image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.258
-3.94 %
$ 1.61 M
Market Cap
-0.08
P/E
CASH FLOW STATEMENT
-7.33 M OPERATING CASH FLOW
-31.29%
2.92 M INVESTING CASH FLOW
203.04%
3.76 M FINANCING CASH FLOW
46.11%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Shuttle Pharmaceuticals Holdings, Inc.
image
00(1m)(1m)(2m)(2m)(3m)(3m)(4m)(4m)(5m)(5m)(6m)(6m)(7m)(7m)(8m)(8m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -9.14 M
Depreciation & Amortization 5.46 K
Capital Expenditures 0
Stock-Based Compensation 260 K
Change in Working Capital 139 K
Others 1.24 M
Free Cash Flow -7.33 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (9.1) (6.6) (3.0) (1.2) (0.8) (0.6) (0.2)
Depreciation & Amortization 5.46 K 6.81 K 66.8 K 60.8 K 55 K 18 K 18.7 K
Deferred Income Tax 0 0 0 (0.6) 0 0 0
Stock Based Compensation 0.3 0.2 0.4 0.9 0.5 0 0
Other Operating Activities 1.4 0.6 0.4 3.39 K 0.3 63.8 K 58.5 K
Change in Working Capital 0.1 0.2 (0.6) 0.5 7.78 K 16.6 K 9.03 K
Cash From Operations (7.3) (5.6) (2.7) (0.3) 26.8 K (0.6) (0.2)
INVESTING CASH FLOW
Capital Expenditures 0 19 K 0 0 10.8 K 0 0
Other Items 2.9 (2.8) 0 0 0 0 0
Cash From Investing Activities 2.9 (2.8) 0 0 10.8 K 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0
Total Debt Repaid 0.1 2.9 0.6 0.7 70.1 K 0.2 0.2
Dividends Paid 0 0 (0.4) 0 0 0 0
Other Financing Activities (0.4) (0.3) 0.4 0 0 (0.2) 0
Cash From Financing Activities 3.8 2.6 10.6 0.7 70.1 K 0.9 0.2
CHANGE IN CASH
Net Change In Cash (0.7) (5.8) 7.9 0.4 32.4 K 0.3 42.1 K
FREE CASH FLOW
Free Cash Flow (7.3) (5.6) (2.7) (0.3) 37.6 K (0.6) (0.2)